what glp-1 are approved for weight loss List of and pending medications Is GLP-1 the Same as

Arnott C, Huang Y, Neuen BL, et al

Medical review (2021)

For people with diabetes, rapid improvement in blood glucose control may occasionally be associated with transient worsening of diabetic retinopathy

Dapagliflozin is a weak substrate of the P-glycoprotein (P-gp) active transporter, and dapagliflozin 3-O-glucuronide is a substrate for the OAT3 active transporter

Additionally, there were more deaths in the Tirzepatide group than semaglutide (12 vs 1)

According to the results, the GLP-1 group was more likely to be diagnosed with NAION than the control group, which was prescribed sodium-glucose cotransporter-2 inhibitors